UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

British journal of cancer, 2005-01, Vol.92 (2), p.342-349

2005

Volltextzugriff (PDF)

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

International journal of cancer, 2005-05, Vol.115 (1), p.98-104

2005

Volltextzugriff (PDF)

Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma

Hepatology research, 2006, Vol.34 (1), p.50-56

2006

Volltextzugriff (PDF)

Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state

Blood, 1997-03, Vol.89 (5), p.1665-1677

1997

Volltextzugriff (PDF)

Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients

Transplantation, 2001-08, Vol.72 (4), p.736

2001

Volltextzugriff (PDF)

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Cancer Immunology, Immunotherapy, 2006-05, Vol.55 (5), p.503-514

2006

Volltextzugriff (PDF)

Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1

Journal of Virology, 1995-04, Vol.69 (4), p.2644-2648

1995

Volltextzugriff (PDF)

The formulation and immunogenicity of therapeutic proteins: Product quality as a key factor

IDrugs : the investigational drugs journal, 2010-08, Vol.13 (8), p.550

2010

Volltextzugriff (PDF)

Negatively cis-acting elements in the distal part of the promoter of Epstein--Barr virus trans-activator gene BZLF1

Journal of general virology, 1994-08, Vol.75 (8), p.1999-2006

1994

Volltextzugriff (PDF)

The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review)

International journal of molecular medicine, 1998-01, Vol.1 (1), p.137

1998

Volltextzugriff (PDF)

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Molecular Immunology, 2006-03, Vol.43 (8), p.1183-1193

2006

Volltextzugriff (PDF)

A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer

Journal of immunological methods, 2007-06, Vol.323 (2), p.180-193

2007

Volltextzugriff (PDF)

Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: A novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease

Cancer research (Chicago, Ill.), 2002, Vol.62 (1), p.251-261

2002

Volltextzugriff (PDF)

Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1

Journal of medical virology, 1999-12, Vol.59 (4), p.512-519

1999

Volltextzugriff (PDF)

A Case of Severe Chronic Active Infection with Epstein-Barr Virus: Immunologic Deficiencies Associated with a Lytic Virus Strain

Clinical infectious diseases, 1999-09, Vol.29 (3), p.626-631

1999

Volltextzugriff (PDF)

Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis

British journal of haematology, 1995-07, Vol.90 (3), p.526-531

1995

Volltextzugriff (PDF)

Role of Epstein‐Barr virus and soluble CD21 in persistent polyclonal B‐cell lymphocytosis

British journal of haematology, 1995-07, Vol.90 (3), p.532-540

1995

Volltextzugriff (PDF)

Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State

Blood, 1997-03, Vol.89 (5), p.1665-1677

1997

Volltextzugriff (PDF)

Epstein‐Barr virus‐infected B cells of males with the X‐linked lymphoproliferative syndrome stimulate and are susceptible to T‐cell‐mediated lysis

International journal of cancer, 1998-05, Vol.76 (5), p.694-701

1998

Volltextzugriff (PDF)

Epstein-Barr Viral Gene Expression in B-Lymphocytes

Leukemia & lymphoma, 1998-06, Vol.30 (1-2), p.23-129

1998

Volltextzugriff (PDF)

Epstein-Barr Viral Gene Expression in B-Lymphocytes

Leukemia & lymphoma, 1998, Vol.30 (1-2), p.123-129

1998

Volltextzugriff (PDF)

Pathogenesis of chronic Epstein‐Barr virus infection: detection of a virus strain with a high rate of lytic replication

British journal of haematology, 1996-12, Vol.95 (4), p.626-636

1996

Volltextzugriff (PDF)

Lytic replication of Epstein-Barr virus is controlled by a posttranscriptional regulation mechanism for the immediate early gene BZLF1

Journal of cancer research and clinical oncology, 1995-01, Vol.121 (S1), p.S21-S21

1995

Volltextzugriff (PDF)

Specific binding of KU factor and downregulation of the promoter of the lytic cycle gene BZLF1 of Epstein-Barr virus

Journal of cancer research and clinical oncology, 1995-01, Vol.121 (S1), p.S21-S21

1995

Volltextzugriff (PDF)

Identification of Epstein-Barr virus transactivator BZLF1 mRNA in uncultured peripheral blood lymphocytes by RT-polymerase chain reaction

Experientia, 1994-09, Vol.50 (9), p.796-796

1994

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Humans
(20)
Biological And Medical Sciences
(16)
Medical Sciences
(11)
Epstein-Barr Virus
(7)
Female
(7)
Male
(7)
B-Lymphocytes - Virology
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Herpesvirus 4, Human - Genetics
(6)
Oncology
(6)
Animals
(5)
Cell Line
(5)
Gene Expression Regulation, Viral
(5)
Hematology
(5)
Immunology
(5)
Transcription, Genetic
(5)
Virus Replication
(5)
B-Lymphocytes - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma

Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state

Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1

The formulation and immunogenicity of therapeutic proteins: Product quality as a key factor

Negatively cis-acting elements in the distal part of the promoter of Epstein--Barr virus trans-activator gene BZLF1

The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review)

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer

Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: A novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease

Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1

A Case of Severe Chronic Active Infection with Epstein-Barr Virus: Immunologic Deficiencies Associated with a Lytic Virus Strain

Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis

Role of Epstein‐Barr virus and soluble CD21 in persistent polyclonal B‐cell lymphocytosis

Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State

Epstein‐Barr virus‐infected B cells of males with the X‐linked lymphoproliferative syndrome stimulate and are susceptible to T‐cell‐mediated lysis

Epstein-Barr Viral Gene Expression in B-Lymphocytes

Epstein-Barr Viral Gene Expression in B-Lymphocytes

Pathogenesis of chronic Epstein‐Barr virus infection: detection of a virus strain with a high rate of lytic replication

Lytic replication of Epstein-Barr virus is controlled by a posttranscriptional regulation mechanism for the immediate early gene BZLF1

Specific binding of KU factor and downregulation of the promoter of the lytic cycle gene BZLF1 of Epstein-Barr virus

Identification of Epstein-Barr virus transactivator BZLF1 mRNA in uncultured peripheral blood lymphocytes by RT-polymerase chain reaction

Suchergebnisse filtern